Literature DB >> 21502753

Long-term treatment with fumaric acid esters in an 11-year-old male child with psoriasis.

S Gerdes1, S Domm, U Mrowietz.   

Abstract

Moderate to severe psoriasis is common in childhood and adolescence and is often a challenge for the treating dermatologist. In most cases, systemic therapies in children are only available 'off-label'. Fumaric acid esters (FAEs) have been used successfully in the treatment of moderate to severe psoriasis in adults and are recommended for long-term treatment in the German S3 guideline. In childhood psoriasis, FAEs may be a treatment alternative if a systemic therapy is indicated. Here, we report about the successful long-term treatment with FAEs in a male child with severe psoriasis.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21502753     DOI: 10.1159/000327086

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  3 in total

Review 1.  [Children and adolescents with psoriasis. What therapy is recommended?].

Authors:  M Sticherling
Journal:  Hautarzt       Date:  2012-03       Impact factor: 0.751

Review 2.  Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities.

Authors:  I M G J Bronckers; A S Paller; M J van Geel; P C M van de Kerkhof; M M B Seyger
Journal:  Paediatr Drugs       Date:  2015-10       Impact factor: 3.022

Review 3.  Fumaric acid esters in the management of psoriasis.

Authors:  Deepak Mw Balak
Journal:  Psoriasis (Auckl)       Date:  2015-01-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.